Wall Street Anticipates Amgen’s Weight-Loss Drug Data: A Potential Market Mover
Amgen, a global biotechnology leader, is poised to release critical data on its highly anticipated weight-loss drug. Investors, analysts, and the broader healthcare industry are closely watching this development, which could significantly impact Amgen’s market valuation and redefine the competitive landscape in the weight-loss medication sector. With obesity rates surging globally and weight-management drugs capturing […]